Skip to main content
Signal8

Ellis Andrea

SEC insider (Form 3/4/5 filer). CIK 0001877680. Director at BridgeBio Pharma, Inc. (BBIO). 12 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in PALO ALTO, CA.

Companies Ellis Andrea has filed insider reports for

  • BridgeBio Pharma, Inc. (BBIO): Director
Ellis Andrea profile photo

Ellis Andrea

CIK: 0001877680

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (41.7%)

Position reduction

Option Exercises (M)5 (41.7%)

Derivative conversions

Awards (A)2 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BridgeBio Pharma, Inc. logo
BBIO

BridgeBio Pharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (12 total)

  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Jul 9, 2026
    Sale
    Direct
    17.2K shares at avg. $84.00$1.4M
  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Jul 9, 2026
    Exercise
    Direct
    17.2K shares at avg. $16.75$288K
  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Jun 22, 2026
    Award
    Direct
    4K shares-
  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Mar 4, 2026
    Sale
    Direct
    64.9K shares at avg. $64.87$4.2M
  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Mar 4, 2026
    Exercise
    Direct
    64.9K shares at avg. $8.45$549K
  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Aug 5, 2025
    Exercise
    Direct
    17.2K shares at avg. $16.75$288K
  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Aug 5, 2025
    Sale
    Direct
    17.2K shares at avg. $49.00$841K
  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Jun 20, 2025
    Award
    Direct
    6.6K shares-
  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Apr 14, 2025
    Sale
    Direct
    10K shares at avg. $35.00$350K
  • BridgeBio Pharma, Inc. logo
    BBIO

    BridgeBio Pharma, Inc.

    Apr 14, 2025
    Exercise
    Direct
    10K shares at avg. $8.45$85K

1-10 of 12